[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.238.248.103. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Year

Day

July 29, 2020
Editorial

Consensus, Controversy, and Conversations About Gene Expression Profiling in Melanoma

Abstract Full Text
has audio
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.1730
Original Investigation

Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.1731

This systematic review and meta-analysis assesses the performance of commercially available gene expression profile tests for prognosis of cutaneous melanoma in patients with stage I or stage II melanoma

Consensus Statement

Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit

Abstract Full Text
has audio
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.1729

This consensus statement assesses what evidence is needed to develop guidelines on integration of gene expression profile testing into cutaneous melanoma management.

Images in Dermatology

Bart-Pumphrey Syndrome

Abstract Full Text
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.2555

This case report describes a young man with Bart-Pumphrey syndrome, a rare genetic disorder affecting both the skin of the hands and the hearing.

Research Letter

Association of Sensorineural Hearing Loss in Patients With Alopecia Areata: A Nationwide Population-Based Cohort Study

Abstract Full Text
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.2430

This nationwide population-based cohort study investigates the risk of hearing loss in patients with alopecia areata using claims data from the National Health Insurance Research Database in Taiwan.

JAMA Dermatology Patient Page

Central Centrifugal Cicatricial Alopecia

Abstract Full Text
free access
JAMA Dermatol. Published online July 29, 2020. doi:10.1001/jamadermatol.2020.1859

This Patient Page describes the symptoms, possible causes, and treatment of central centrifugal cicatricial alopecia.

July 22, 2020
Original Investigation

Frontline BRAF Testing–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies: A Cost-Utility Analysis Based on Long-term Survival Data

Abstract Full Text
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2398

This cost-utility analysis compares the cost-utility of these novel agents and their combinations with or without BRAF gene testing guidance for treating newly diagnosed advanced melanoma with unknown BRAF status.

Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase–4 Inhibitor vs Second-generation Sulfonylurea

Abstract Full Text
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2158

This cohort study analyzed data from 2 large commercial insurance claims databases to characterize the incidence rate of bullous pemphigoid associated with the use of dipeptidyl peptidase–4 inhibitors.

Images in Dermatology

Follmann Balanitis—An Atypical Form of Primary Cutaneous Syphilis

Abstract Full Text
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2275

This case report describes a man with Follmann balanitis, an atypical form of primary cutaneous syphilis.

Research Letter

Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017

Abstract Full Text
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2427

This cross-sectional study evaluates the geographical variation in the availability of photodynamic therapy for the Medicare population in the United States and characterizes the temporal trends of photodynamic therapy cost and use from 2012 to 2017.

Observation

Early Features of Progressive Hemifacial Atrophy–Clinical and Imaging Findings

Abstract Full Text
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2593

This case report describes 3 children with clinical and imaging features of progressive hemifacial atrophy.

Correction

Error in Results Section

Abstract Full Text
free access
JAMA Dermatol. Published online July 22, 2020. doi:10.1001/jamadermatol.2020.2764
July 15, 2020
Original Investigation

Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma

Abstract Full Text
JAMA Dermatol. Published online July 15, 2020. doi:10.1001/jamadermatol.2020.2149

This cohort study examines whether anti–programmed cell death 1 antibody (anti–PD-1) therapy is associated with reduced risk of recurrence of toxic effects in patients with metastatic melanoma who experienced severe immune-related adverse effects (AEs) after receipt of ipilimumab therapy.

Research Letter

Association of Topical Minoxidil With Autosomal Recessive Woolly Hair/Hypotrichosis Caused by LIPH Pathogenic Variants

Abstract Full Text
JAMA Dermatol. Published online July 15, 2020. doi:10.1001/jamadermatol.2020.2195

This nonrandomized clinical trial evaluates the association of topical minoxidil with hypotrichosis in patients with autosomal recessive woolly hair/hypotrichosis carrying LIPH pathogenic variants.

Enanthem in Patients With COVID-19 and Skin Rash

Abstract Full Text
free access
JAMA Dermatol. Published online July 15, 2020. doi:10.1001/jamadermatol.2020.2550

This case series describes the appearance of enanthem (oral cavity lesions) in patients with COVID-19.

Comment & Response

Correlation Between Dermoscopic and Histologic Features of Uncommon Cutaneous Melanoma Variants

Abstract Full Text
JAMA Dermatol. Published online July 15, 2020. doi:10.1001/jamadermatol.2020.2480

Correlation Between Dermoscopic and Histologic Features of Uncommon Cutaneous Melanoma Variants—Reply

Abstract Full Text
JAMA Dermatol. Published online July 15, 2020. doi:10.1001/jamadermatol.2020.1973
July 8, 2020
Original Investigation

Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment

Abstract Full Text
JAMA Dermatol. Published online July 8, 2020. doi:10.1001/jamadermatol.2020.2330

This case series uses Skindex-16 scores to assess the association between having skin disease and quality of life among patients with acne who are receiving isotretinoin treatment.

Review

Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review

Abstract Full Text
JAMA Dermatol. Published online July 8, 2020. doi:10.1001/jamadermatol.2020.2327

This systematic review examines the evidence of the use of capecitabine for the treatment and prevention of precancerous and cancerous skin lesions.

Images in Dermatology

Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus

Abstract Full Text
JAMA Dermatol. Published online July 8, 2020. doi:10.1001/jamadermatol.2020.2415

This case report describes a man in his 80s who had a rash composed of erythematous polycyclic plaques with peripheral scale and central hyperpigmentation.

July 1, 2020
Editorial

Outcomes of Embedding Dermatologic Care Within Oncology Practices for Patients With Cancer

Abstract Full Text
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1794
Original Investigation

Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center

Abstract Full Text
has audio
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1795

This cohort study evaluates the association of a comprehensive skin toxicity program for patients with cancer with adherence to prophylaxis guidelines for the prevention of epidermal growth factor receptor inhibitor–associated cutaneous toxic effects at the Dana-Farber Cancer Institute.

Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In Situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In Situ vs the General Population in the Netherlands, 1989-2017

Abstract Full Text
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1988

This cohort study uses data from the Netherlands Cancer Registry to assess the incidence rates of cutaneous squamous cell carcinoma in situ and the risk of developing invasive cutaneous squamous cell carcinoma among patients compared with the general population in the Netherlands from 1989 to 2017.

Research Letter

Dermatoscopic Evaluation of Central Centrifugal Cicatricial Alopecia Beyond the Vertex Scalp

Abstract Full Text
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1287

This cross-sectional study assesses the dermatoscopic findings of central centrifugal cicatricial alopecia beyond the vertex scalp.

Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion

Abstract Full Text
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1984

This cohort study compares the use of adjuvant radiotherapy following surgery with surgery alone in patients treated for cutaneous squamous cell carcinoma with perineural invasion.

Observation

Necrolytic Acral Erythema in Association With Hypothyroidism

Abstract Full Text
JAMA Dermatol. Published online July 1, 2020. doi:10.1001/jamadermatol.2020.1976

This case report describes 5 patients with hypothyroidism who presented with lesions typically associated with hepatitis C virus infection even though they were seronegative for this disease.

×